ESC Heart Failure · 2016 · 78 citations · 31 references
MedicineCardiologyEndocrinologyEndocrine Nuclear MedicineEndocrine SurgeryStructural Heart DiseaseHeart FailureThyroid DisordersThyroid EndocrinologyAcute Decompensated Valvular Heart DiseaseSubclinical Hyperthyroidism AssessmentSubclinical HypothyroidismThyroid Function EvaluationThyroid Function TestingThyroid Function TestsThyroid Hormone Metabolism AlterationsTriiodothyronine Measurement
Abstract Aims Altered thyroid hormone metabolism characterized by a low triiodothyronine (T3), so-called low-T3 syndrome, is a common finding in patients with severe systemic diseases. Additionally, subclinical thyroid dysfunction, defined as abnormal thyroid stimulating hormone (TSH) and normal thyroxine (T4), causes left ventricular dysfunction. Our objective was to identify the prevalence and prognostic impact of low-T3 syndrome and subclinical thyroid dysfunction in patients with acute decompensated heart failure (ADHF). Methods and results We examined 274 ADHF patients who were not receiving thyroid medication or amiodarone on admission (70 ± 15 years, 156 male), who underwent thyroid function tests. Euthyroidism was defined as TSH of 0.45 to 4.49 mIU/L; subclinical hypothyroidism as TSH of 4.5 to 19.9 mIU/L; and subclinical hyperthyroidism as TSH < 0.45 mIU/L, with normal free T4 level for the last two. Additionally, low-T3 syndrome was defined as free T3 < 4.0 pmol/L among euthyroidism subjects. On admission, 188 patients (69%) showed euthyroidism, 58 (21%) subclinical hypothyroidism, 5 (2%) subclinical hyperthyroidism, and 95 (35%) low-T3 syndrome. Cox proportional hazards models revealed that higher TSH, but not free T3 and free T4, was independently associated with composite cardiovascular events, including cardiac death and re-hospitalization for heart failure. Indeed, subclinical hypothyroidism was an independent predictor (hazard ratio: 2.31; 95% confidence interval: 1.44 to 3.67; P < 0.001), whereas low-T3 syndrome and subclinical hyperthyroidism were not. Conclusions Subclinical hypothyroidism on admission was an independent predictor of adverse cardiovascular outcomes in ADHF patients, suggesting a possible interaction between thyroid dysfunction and the pathophysiology of ADHF.
31
2013 ACCF/AHA Guideline for the Management of Heart Failure
Clyde W. Yancy, Mariell Jessup, Biykem Bozkurt et al. · Journal of the American College of Cardiology · 2013 · 12.6K citations
The Colorado Thyroid Disease Prevalence Study
Gay J. Canaris, Neil Manowitz, Gilbert H. Mayor et al. · Archives of Internal Medicine · 2000 · 2.8K citations
Trends in Heart Failure Incidence and Survival in a Community-Based Population
Véronique L. Roger · JAMA · 2004 · 1.6K citations